Genome-wide CRISPR screen uncovers a synergistic effect of combining Haspin and Aurora kinase B inhibition
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genome-wide CRISPR screen uncovers a synergistic effect of combining Haspin and Aurora kinase B inhibition
Authors
Keywords
-
Journal
ONCOGENE
Volume 39, Issue 21, Pages 4312-4322
Publisher
Springer Science and Business Media LLC
Online
2020-04-16
DOI
10.1038/s41388-020-1296-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- E2F1 proteolysis via SCF ‐cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition
- (2019) Kamila Burdova et al. EMBO JOURNAL
- Haspin: a promising target for the design of inhibitors as potent anticancer drugs
- (2018) Nathalie Gisèle Amoussou et al. DRUG DISCOVERY TODAY
- The functional diversity of Aurora kinases: a comprehensive review
- (2018) Estelle Willems et al. Cell Division
- Genome-wide CRISPR screens reveal synthetic lethality of RNASEH2 deficiency and ATR inhibition
- (2018) Chao Wang et al. ONCOGENE
- A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies
- (2017) Ankit C. Borisa et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagy
- (2017) Christoph Potting et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aurora kinases: novel therapy targets in cancers
- (2017) Anqun Tang et al. Oncotarget
- Aurora-A promotes the establishment of spindle assembly checkpoint by priming the Haspin-Aurora-B feedback loop in late G2 phase
- (2017) Fazhi Yu et al. Cell Discovery
- Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
- (2016) Shanthi Marur et al. MAYO CLINIC PROCEEDINGS
- Aurora kinase targeting in lung cancer reduces KRAS-induced transformation
- (2016) Edmilson Ozorio dos Santos et al. Molecular Cancer
- Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo
- (2016) B. A. Helfrich et al. MOLECULAR CANCER THERAPEUTICS
- Essential role of autoactivation circuitry on Aurora B-mediated H2AX-pS121 in mitosis
- (2016) Midori Shimada et al. Nature Communications
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
- (2015) Traver Hart et al. CELL
- MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
- (2015) Todd B. Sells et al. ACS Medicinal Chemistry Letters
- Aurora Kinase Inhibitors: Current Status and Outlook
- (2015) Vassilios Bavetsias et al. Frontiers in Oncology
- Polo-like kinase-1 triggers histone phosphorylation by Haspin in mitosis
- (2014) Linli Zhou et al. EMBO REPORTS
- Aurora kinases in head and neck cancer
- (2013) Ranee Mehra et al. LANCET ONCOLOGY
- Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancer
- (2013) Masafumi Takeshita et al. LUNG CANCER
- Autoinhibition and Polo-Dependent Multisite Phosphorylation Restrict Activity of the Histone H3 Kinase Haspin to Mitosis
- (2013) Cristina Ghenoiu et al. MOLECULAR CELL
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Haspin inhibitors reveal centromeric functions of Aurora B in chromosome segregation
- (2012) Fangwei Wang et al. JOURNAL OF CELL BIOLOGY
- Molecular basis for phosphospecific recognition of histone H3 tails by Survivin paralogues at inner centromeres
- (2012) Ewa Niedzialkowska et al. MOLECULAR BIOLOGY OF THE CELL
- Structural Basis for Recognition of H3T3ph and Smac/DIABLO N-terminal Peptides by Human Survivin
- (2012) Jiamu Du et al. STRUCTURE
- A General Framework for Inhibitor Resistance in Protein Kinases
- (2011) Deborah Balzano et al. CHEMISTRY & BIOLOGY
- A Positive Feedback Loop Involving Haspin and Aurora B Promotes CPC Accumulation at Centromeres in Mitosis
- (2011) Fangwei Wang et al. CURRENT BIOLOGY
- Structural Basis for the Recognition of Phosphorylated Histone H3 by the Survivin Subunit of the Chromosomal Passenger Complex
- (2011) A. Arockia Jeyaprakash et al. STRUCTURE
- Aurora kinase inhibitors as anticancer molecules
- (2010) Hiroshi Katayama et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Two Histone Marks Establish the Inner Centromere and Chromosome Bi-Orientation
- (2010) Yuya Yamagishi et al. SCIENCE
- Survivin Reads Phosphorylated Histone H3 Threonine 3 to Activate the Mitotic Kinase Aurora B
- (2010) Alexander E. Kelly et al. SCIENCE
- Histone H3 Thr-3 Phosphorylation by Haspin Positions Aurora B at Centromeres in Mitosis
- (2010) Fangwei Wang et al. SCIENCE
- The discovery of the potent aurora inhibitor MK-0457 (VX-680)
- (2009) David Bebbington et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Clinical Experience with Aurora Kinase Inhibitors: A Review
- (2009) D. S. Boss et al. ONCOLOGIST
- Structure and functional characterization of the atypical human kinase haspin
- (2009) J. Eswaran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More